Member Info for Saint68

DTM - nothing under 'Avacta Investor discussion group' so I'll give it a miss.

Said as a fact when in reality you have no idea.

DTW - what is the name of the group please. I've tried Avacta and there were only 3 results - none are applicable.

Do you have a link to the group please DTW ?

Good - you had me worried there for a moment. IMO, if the treatment does get approved after successful trials, it will not been under Hemogenyx control - we will be bought out or Car-T will be sold to fund the development of CBR.

You don’t think they’re treating the patients at the lab do you ?? No chance that will be happening.

Few more numpties into the bin this morning. Pharma investing definitely is not for you.

They're definitely a pair - a pair of c1_1nts. Binned months ago.

DCT - how can you expect clinical trials to be have been nearly sorted prior to clinical hold lift. Are you saying we should have had a raft of patients ready to go - when we didn't know 100% that it would be lifted ? How do you think those patients would have felt if they were then let down ?

Yes they do but I doubt anyone on these boards would possess any. From the November RNS :

Queeld Ventures Limited and Mispare Limited (respectively "Queeld" and "Mispare") are registered shareholders in Eurasia Mining PLC ("Eurasia"). In or about July 2018, Queeld and Mispare applied to Eurasia for the issue of replacement share certificates in respect of their respective shareholdings.

James - "held in a trading account" - definitely not. The whole issue is around lost certificates.

Thanks for the update LB

LB - I don't think the full document has been posted on the Telegram group. It was a link to the page you supplied. I think they're waiting on one of the posters to see if he can access the whole document.

Datta- “he loves Russia and its people” - that one comment is enough to put you in the bin.

As long as his people do exactly as he commands they’ll be fine but step out of line and ….. the rest is history. No freedom of speech and those who do speak freely find themselves falling out of a very high window. Binned

Currently on hols so only have my Ipad and when I try to download I get a load of text which is unreadable - see below. I’m a pharmacist so know exactly who constitutes big pharma.

id":"J14124"},"secondaryIdInfos":[{"id":"IRB00046315","type":"OTHER","domain":"JHMIRB"},{"id":"P50CA103175","type":"NIH","link":"https://reporter.nih.gov/quickSearch/P50CA103175"}],"organization":{"fullName":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","class":"OTHER"},"briefTitle":"Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET","officialTitle":"Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET"},"statusModule":{"statusVerifiedDate":"2023-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-02-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-05-01","type":"ACTUAL"},"completionDateStruct":{"date":"2022-05-01","type":"ACTUAL"},"studyFirstSubmitDate":"2015-01-13","studyFirstSubmitQcDate":"2018-05-18","studyFirstPostDateStruct":{"date":"2018-05-31","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-01-09","lastUpdatePostDateStruct":{"date":"2023-01-11","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","class":"OTHER"},"collaborators":[{"name":"National Cancer Institute (NCI)","class":"NIH"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"To use 18F-DCFPyL imaging agent and PET/CT to detect none prostate cancer solid malignancies and schwannoma tumors.","detailedDescription":"The purpose of this protocol is to extend our existing patient base from those with prostate cancer to those with any solid

D-Geeman- “ but if he spilts off the DX side then that only leave the precision platform”- this is not correct. He can split off the DX side and still keep the Affimer platform. He can then license it out.

“ Think we all know that most of these studies were run by big pharma”. - you can’t possibly know that JHFH. It’s a pure guess on your part. You shouldn’t promote your opinion as fact.

I do agree that Vlad will be hopefully be looking to license as soon as possible though.

JHFH - below is a link to info on clinical trial costs. Average cost for a phase 1 trial is 4.5m and this was in 2015 / 16 so likely higher now.

https://www.sofpromed.com/how-much-does-a-clinical-trial-cost

That would be brilliant Haywain 😂

Agree that it’s a total s.it show here these days. Must disagree that you don’t normally reply - most of the chat here is you constantly replying to the likes of MrI, 121, Stu and the other twats.

I think I now only have about 10 posters whose comments I can read - the rest are binned.

Haywain is by far the best poster on this board and I’m very grateful for his input.